335 related articles for article (PubMed ID: 18056833)
41. Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease.
Starr JM; Lonie J
Dement Geriatr Cogn Disord; 2007; 24(5):343-7. PubMed ID: 17890863
[TBL] [Abstract][Full Text] [Related]
42. Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease.
Hamuro A
Aust N Z J Psychiatry; 2013 Jun; 47(6):583. PubMed ID: 23093052
[No Abstract] [Full Text] [Related]
43. Memantine (Ebixa) in clinical practice - results of an observational study.
Calabrese P; Essner U; Forstl H
Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
[TBL] [Abstract][Full Text] [Related]
44. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
45. Treatment effects of Ginkgo biloba extract EGb 761® on the spectrum of behavioral and psychological symptoms of dementia: meta-analysis of randomized controlled trials.
Savaskan E; Mueller H; Hoerr R; von Gunten A; Gauthier S
Int Psychogeriatr; 2018 Mar; 30(3):285-293. PubMed ID: 28931444
[TBL] [Abstract][Full Text] [Related]
46. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.
Ma H; Huang Y; Cong Z; Wang Y; Jiang W; Gao S; Zhu G
J Alzheimers Dis; 2014; 42(3):915-37. PubMed ID: 25024323
[TBL] [Abstract][Full Text] [Related]
47. Memantine for dementia.
Areosa SA; Sherriff F; McShane R
Cochrane Database Syst Rev; 2005 Jul; (3):CD003154. PubMed ID: 16034889
[TBL] [Abstract][Full Text] [Related]
48. Memantine for dementia.
Areosa SA; Sherriff F; McShane R
Cochrane Database Syst Rev; 2005 Apr; (2):CD003154. PubMed ID: 15846650
[TBL] [Abstract][Full Text] [Related]
49. Memantine in behavioral variant frontotemporal dementia: negative results.
Vercelletto M; Boutoleau-Bretonnière C; Volteau C; Puel M; Auriacombe S; Sarazin M; Michel BF; Couratier P; Thomas-Antérion C; Verpillat P; Gabelle A; Golfier V; Cerato E; Lacomblez L;
J Alzheimers Dis; 2011; 23(4):749-59. PubMed ID: 21157021
[TBL] [Abstract][Full Text] [Related]
50. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation.
Keck PE; Hsu HA; Papadakis K; Russo J
Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854
[TBL] [Abstract][Full Text] [Related]
51. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
52. Memantine: update on the current evidence.
Möbius HJ
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S47-54. PubMed ID: 12973750
[TBL] [Abstract][Full Text] [Related]
53. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain].
Robles-Bayón A
Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592
[TBL] [Abstract][Full Text] [Related]
54. Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions.
Ballard C; Corbett A; Chitramohan R; Aarsland D
Curr Opin Psychiatry; 2009 Nov; 22(6):532-40. PubMed ID: 19696673
[TBL] [Abstract][Full Text] [Related]
55. Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study.
Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Lazzeroni L; Rasgon NL
Acta Neurol Scand; 2009 Mar; 119(3):172-9. PubMed ID: 18705678
[TBL] [Abstract][Full Text] [Related]
56. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
Lim HK; Pae CU; Lee C; Lee CU
Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
[TBL] [Abstract][Full Text] [Related]
57. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
Schifitto G; Navia BA; Yiannoutsos CT; Marra CM; Chang L; Ernst T; Jarvik JG; Miller EN; Singer EJ; Ellis RJ; Kolson DL; Simpson D; Nath A; Berger J; Shriver SL; Millar LL; Colquhoun D; Lenkinski R; Gonzalez RG; Lipton SA; ; ;
AIDS; 2007 Sep; 21(14):1877-86. PubMed ID: 17721095
[TBL] [Abstract][Full Text] [Related]
58. Tinnitus treatment with memantine.
Figueiredo RR; Langguth B; Mello de Oliveira P; Aparecida de Azevedo A
Otolaryngol Head Neck Surg; 2008 Apr; 138(4):492-6. PubMed ID: 18359360
[TBL] [Abstract][Full Text] [Related]
59. Treatment of dementia: anything new?
Machado JC; Caramelli P
Curr Opin Psychiatry; 2006 Nov; 19(6):575-80. PubMed ID: 17012934
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological treatment of dementia.
Schwarz S; Froelich L; Burns A
Curr Opin Psychiatry; 2012 Nov; 25(6):542-50. PubMed ID: 22992546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
